Source: International Congress 2016 – Airway response to infection
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Marcel José Rodriguez Guzman (Las Rozas (Madrid), Spain), Marcel José Rodriguez Guzman, Felipe Villar Álvarez, Cristina Serrano del Castillo, Miguel Ángel Palomero Rodríguez, Yolanda Laporta Báez, Germán Peces-Barba Romero. Identification of novel pathogenic mechanisms triggered by arginase activation in patients with COPD. Eur Respir J 2016; 48: Suppl. 60, 3981

Member's Comments

No comment yet.

Related content which might interest you: Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Expression of vascular remodeling markers in relation to bradykinin receptors in asthma and COPD Source: Annual Congress 2013 –Emerging new targets for the treatment of respiratory diseases Year: 2013 Sputum cell mRNA transcripts demonstrate alteration of endothelin metabolism in severe asthma and COPD Source: Annual Congress 2013 –New drugs in respiratory medicine Year: 2013 Investigation the role of pentraxin-3 in the innate immune system in patients with COPD Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Identification of therapeutic targets for steroid-insensitive asthma using models that represent different clinical subtypes of disease Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding Year: 2016 Modulation of inflammation by benralizumab in eosinophilic airway disease Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016 PTX3 a marker of innate immune responses in the airways of asthmatics and COPD patients Source: Annual Congress 2013 –Asthma: new mechanisms and markers Year: 2013 Bronchial epithelial gene expression of NOX isoforms are related to important clinical characteristics in COPD Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 The role of antioxidant enzymes in the pathogenesis of asthma and the formation of the features of its clinical course Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015 IL-17A is elevated in patients with COPD and contributes to airway remodeling by acting on fibroblasts Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016 Autoreactivity and inflammatory phenotypes in patients with COPD and bronchial asthma Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 The correlation between expression of selected inflammatory mediators in induced sputum and respiratory tests in asthma and COPD Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 Cytokine patterns and latent viruses in patients with severe asthma and COPD Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Imbalance of immune response functional phenotype and alveolar macrophages phenotype in COPD Source: International Congress 2014 – New insights into monocyte and macrophage biology Year: 2014 Steroid resistance in COPD is associated with impaired molecular chaperone HSP90 expression by pro-inflammatory lymphocytes Source: International Congress 2016 – Mechanisms of disease Year: 2016 Cellular mechanisms underlying CCSP SNP association with chronic airway diseases Source: International Congress 2015 – New models for treating airway diseases Year: 2015 Therapeutic blockade of IL-4 and 13 signaling with dupilumab (SAR231893/REGN668) inhibits key biomarkers in asthma Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Identification of novel genes related to airway obstruction in never-smokers Source: International Congress 2015 – Genetics, genomics and exposures in asthma and COPD Year: 2015 WNT-4 regulates pro-inflammatory responses driven by epithelial-mesenchymal cross-talk Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action Year: 2016 Similar adaptive immune response in COPD patients with and without alpha1 antitrypsin deficiency Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013